Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

SAB Biotherapeutics (SABSW) Exchange Rate Effect (2024 - 2025)

SAB Biotherapeutics' Exchange Rate Effect history spans 2 years, with the latest figure at -$397861.0 for Q4 2025.

  • For Q4 2025, Exchange Rate Effect fell 37.79% year-over-year to -$397861.0; the TTM value through Dec 2025 reached -$213497.0, up 11.48%, while the annual FY2025 figure was -$213497.0, 11.48% up from the prior year.
  • Exchange Rate Effect reached -$397861.0 in Q4 2025 per SABSW's latest filing, down from -$37537.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $179401.0 in Q2 2025 to a low of -$397861.0 in Q4 2025.